1. Home
  2. PKOH vs RGNX Comparison

PKOH vs RGNX Comparison

Compare PKOH & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park-Ohio Holdings Corp.

PKOH

Park-Ohio Holdings Corp.

HOLD

Current Price

$37.66

Market Cap

526.0M

Sector

Industrials

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$9.90

Market Cap

528.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKOH
RGNX
Founded
1907
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
526.0M
528.6M
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
PKOH
RGNX
Price
$37.66
$9.90
Analyst Decision
Buy
Strong Buy
Analyst Count
1
8
Target Price
$37.00
$28.75
AVG Volume (30 Days)
89.8K
2.9M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
1.69%
N/A
EPS Growth
N/A
18.08
EPS
0.57
N/A
Revenue
$1,599,100,000.00
$10,393,000.00
Revenue This Year
$7.87
$51.21
Revenue Next Year
$3.42
$19.08
P/E Ratio
$67.54
N/A
Revenue Growth
N/A
126.48
52 Week Low
$15.52
$5.46
52 Week High
$39.33
$16.19

Technical Indicators

Market Signals
Indicator
PKOH
RGNX
Relative Strength Index (RSI) 61.59 42.39
Support Level $33.76 $7.84
Resistance Level $39.33 $10.56
Average True Range (ATR) 1.84 1.26
MACD -0.08 -0.48
Stochastic Oscillator 79.57 19.37

Price Performance

Historical Comparison
PKOH
RGNX

About PKOH Park-Ohio Holdings Corp.

Park-Ohio Holdings Corp is a diversified international company offering its clients supply chain management outsourcing services, capital equipment used on their production lines, and manufactured components used to assemble their products. The company operates through three reportable segments: Supply Technologies, Assembly Components, and Engineered Products. Maximum revenue is generated from the Supply Technologies segment, which is mainly engaged in sourcing, planning, and procurement of several production components, including fasteners, pins, nuts, bolts, valves, hoses, wire harnesses, clamps and fittings, etc. Geographically, the company generates maximum revenue from its business in the United States, followed by Europe, Asia, Mexico, Canada, and other regions.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: